By the end of this year, Belarus and Tajikistan may elaborate a roadmap to establish joint ventures in the pharmaceutical industry, announced Oleg Ivanov, the Ambassador of Belarus in Tajikistan and Afghanistan.
AbbVie, a global research biopharmaceutical company, and R-Pharm Group announced the completion of technology transfer for manufacturing Kaletra intended for treatment of HIV/AIDS infection in adult patients.
ABISS, the French company, a manufacturer of implants, together with the Federal Corporation for the Development of Small and Medium Enterprises, prepared a "road map" for manufacturing localization of its products in Russia.
Bayer intends to raise the share of its localized products in Russia to 30% of the total sales. The company is already implementing a number of large-scale projects to localize the manufacturing of innovative medicines